» Articles » PMID: 2033575

Neonatal Screening--should We or Shouldn't We?

Overview
Journal J R Soc Med
Specialty General Medicine
Date 1991 Jan 1
PMID 2033575
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation.

Larsen J, Campbell S, Faragher E, Gotz M, Eichler I, Waldherr S Eur J Pediatr. 1994; 153(8):569-73.

PMID: 7957403 DOI: 10.1007/BF02190660.

References
1.
HEELEY A, Heeley M, King D, Kuzemko J, Walsh M . Screening for cystic fibrosis by died blood spot trypsin assay. Arch Dis Child. 1982; 57(1):18-21. PMC: 2863277. View

2.
Crossley J, Elliott R, Smith P . Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979; 1(8114):472-4. DOI: 10.1016/s0140-6736(79)90825-0. View

3.
Wilcken B, Towns S, Mellis C . Diagnostic delay in cystic fibrosis: lessons from newborn screening. Arch Dis Child. 1983; 58(11):863-6. PMC: 1628396. DOI: 10.1136/adc.58.11.863. View

4.
Wilcken B, Chalmers G . Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet. 1985; 2(8468):1319-21. DOI: 10.1016/s0140-6736(85)92623-6. View

5.
Littlewood J . The sweat test. Arch Dis Child. 1986; 61(11):1041-3. PMC: 1778083. DOI: 10.1136/adc.61.11.1041. View